Skip to main content
. 2017 Mar 4;4(1):e000115. doi: 10.1136/bmjgast-2016-000115

Table 3.

Multivariate logistic analysis

  Rapid viral response
Undetectable or VL ≤15 UI
OR 95% CI p Value OR 95% CI p Value
Treatment initiation (Season A vs Season B) 2.03 1.27 to 3.25 0.003 1.93 1.14 to 3.29 0.014
Type of therapy (lead-in no vs yes) 23.70 10.66 to 52.69 <0.0001 90.1 46.54 to 174.6 <0.0001
HCV RNA (≤600 000 vs >600 000 IU/mL) 2.14 1.29 to 3.55 0.003 4.66 2.36 to 9.17 <0.0001
IL-28 polymorphism (CC vs no CC) 1.94 1.14 to 3.30 0.014 2.24 1.17 to 4.29 0.015
Naïve vs experienced 1.55 0.91 to 2.63 0.10 0.74 0.41 to 1.31 0.30
Genotype (1b vs 1a) 1.32 0.73 to 2.40 0.35 0.71 0.37 to 1.36 0.30
Diabetes mellitus (no vs yes) 1.28 0.63 to 2.61 0.49 1.42 0.66 to 3.05 0.36
Age (≥50 vs <50 years) 0.92 0.55 to 1.52 0.75 1.01 0.58 to 1.78 0.95
Fibrosis (≥F3 vs <F3) 0.92 0.51 to 1.66 0.79 1.63 0.80 to 3.30 0.17

HCV, hepatitis C virus; VL, viral load.